Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in J Thromb Thrombolysis

Retrieve available abstracts of 59 articles:
HTML format

Single Articles

    June 2022
  1. NOVAK AR, Shakowski C, Trujillo TC, Wright GC, et al
    Evaluation of safety and efficacy outcomes of direct oral anticoagulants versus warfarin in normal and extreme body weights for the treatment of atrial fibrillation or venous thromboembolism.
    J Thromb Thrombolysis. 2022 Jun 10. pii: 10.1007/s11239-022-02668.
    PubMed     Abstract available

    May 2022
  2. LIP GYH, Keshishian A, Kang A, Luo X, et al
    Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative claims databases.
    J Thromb Thrombolysis. 2022 May 17. pii: 10.1007/s11239-022-02660.
    PubMed     Abstract available

    April 2022
  3. MARTINEZ KA, Eckman MH, Pappas MA, Rothberg MB, et al
    Prescribing of anticoagulation for atrial fibrillation in primary care.
    J Thromb Thrombolysis. 2022 Apr 21. pii: 10.1007/s11239-022-02655.
    PubMed     Abstract available

  4. DING WY, Rivera-Caravaca JM, Marin F, Roldan V, et al
    Relationship between temporal rhythm-based classification of atrial fibrillation and stroke: real-world vs. clinical trial.
    J Thromb Thrombolysis. 2022 Apr 15. pii: 10.1007/s11239-022-02638.
    PubMed     Abstract available

  5. FROL S, Hudnik LK, Sernec LP, Sabovic M, et al
    Direct oral anticoagulants for secondary stroke prevention in patients over 80 years of age: the role of geriatric functional status.
    J Thromb Thrombolysis. 2022;53:607-615.
    PubMed     Abstract available

  6. DECAMILLO D, Haymart B, Barnes GD
    Adverse events in patients taking apixaban or rivaroxaban who have undergone bariatric surgery: a retrospective case series.
    J Thromb Thrombolysis. 2022;53:601-606.
    PubMed     Abstract available

    February 2022
  7. POTERE N, Candeloro M, Porreca E, Marinari S, et al
    Direct oral anticoagulant plasma levels in hospitalized COVID-19 patients treated with dexamethasone.
    J Thromb Thrombolysis. 2022;53:346-351.
    PubMed     Abstract available

  8. MEADOR S, Dyke S, Togami J, Kuskov B, et al
    Antithrombosis stewardship efforts to de-escalate inappropriate combined therapy in outpatient clinics.
    J Thromb Thrombolysis. 2022;53:436-445.
    PubMed     Abstract available

  9. GALLI M, Gargiulo G
    Towards a personalized selection of antithrombotic agents in patients undergoing PCI: the role of clinical presentation in tools for risk assessment.
    J Thromb Thrombolysis. 2022;53:495-498.

    January 2022
  10. BAI Y, Liu XY, Liu Y, Guo SD, et al
    Prevalence of recommended anticoagulation by guidelines preadmission and its impact on the incidence of acute myocardial infarction (AMI) and in-hospital outcomes after AMI in atrial fibrillation patients.
    J Thromb Thrombolysis. 2022 Jan 24. pii: 10.1007/s11239-021-02622.
    PubMed     Abstract available

    October 2021
  11. LV WH, Dong JZ, Du X, Hu R, et al
    Antithrombotic strategy and its relationship with outcomes in patients with atrial fibrillation and chronic coronary syndrome.
    J Thromb Thrombolysis. 2021 Oct 22. pii: 10.1007/s11239-021-02588.
    PubMed     Abstract available

  12. BEWERSDORF JP, Parmar N, Israel GM, Gettinger SN, et al
    Clinical characteristics and outcomes of splenic infarction in cancer patients: a retrospective, single center report of 206 cases.
    J Thromb Thrombolysis. 2021;52:854-862.
    PubMed     Abstract available

  13. CHEN Y, Zhang Y, Qu L, Huang W, et al
    Short-term non-vitamin K antagonist oral anticoagulants vs. warfarin in preventing device-related thrombosis after left atrial appendage closure.
    J Thromb Thrombolysis. 2021;52:872-879.
    PubMed     Abstract available

  14. NISLY SA, Mihm AE, Gillette C, Davis KA, et al
    Safety of direct oral anticoagulants in patients with mild to moderate cirrhosis: a systematic review and meta-analysis.
    J Thromb Thrombolysis. 2021;52:817-827.
    PubMed     Abstract available

  15. SADIQ H, Hoque L, Shi Q, Manning G, et al
    SUPPORT-AF III: supporting use of AC through provider prompting about oral anticoagulation therapy for AF.
    J Thromb Thrombolysis. 2021;52:808-816.
    PubMed     Abstract available

    September 2021
  16. PAPANASTASIOU A, Kartas A, Samaras A, Vrana E, et al
    Oral anticoagulation patterns and prognosis in octogenarian patients with atrial fibrillation.
    J Thromb Thrombolysis. 2021 Sep 25. pii: 10.1007/s11239-021-02571.
    PubMed     Abstract available

  17. WANG CL, Wu VC, Tu HT, Huang YT, et al
    Risk of major bleeding associated with concomitant use of anticancer drugs and direct oral anticoagulant in patients with cancer and atrial fibrillation.
    J Thromb Thrombolysis. 2021 Sep 23. pii: 10.1007/s11239-021-02570.
    PubMed     Abstract available

  18. OBI CA, Bulsara K, Izard S, Delicce A, et al
    Examination of anticoagulation prescription among elderly patients with atrial fibrillation after in-hospital fall.
    J Thromb Thrombolysis. 2021 Sep 4. pii: 10.1007/s11239-021-02555.
    PubMed     Abstract available

  19. CHEN J, Zhou M, Wang H, Zheng Z, et al
    Risk factors for left atrial thrombus or spontaneous echo contrast in non-valvular atrial fibrillation patients with low CHA2DS2-VASc score.
    J Thromb Thrombolysis. 2021 Sep 2. pii: 10.1007/s11239-021-02554.
    PubMed     Abstract available

    August 2021
  20. MENDOZA PA, McIntyre WF, Belley-Cote EP, Wang J, et al
    Oral anticoagulation for patients with atrial fibrillation in the ED: RE-LY AF registry analysis.
    J Thromb Thrombolysis. 2021 Aug 2. pii: 10.1007/s11239-021-02530.
    PubMed     Abstract available

  21. AFZAL S, Zaidi STR, Merchant HA, Babar ZU, et al
    Prescribing trends of oral anticoagulants in England over the last decade: a focus on new and old drugs and adverse events reporting.
    J Thromb Thrombolysis. 2021;52:646-653.
    PubMed     Abstract available

  22. ROMOLI M, Marchetti G, Bernardini F, Urbinati S, et al
    Switching between direct oral anticoagulants: a systematic review and meta-analysis.
    J Thromb Thrombolysis. 2021;52:560-566.
    PubMed     Abstract available

  23. BASS ME, Kiser TH, Page RL 2nd, McIlvennan CK, et al
    Comparative effectiveness of direct oral anticoagulants and warfarin for the treatment of left ventricular thrombus.
    J Thromb Thrombolysis. 2021;52:517-522.
    PubMed     Abstract available

    July 2021
  24. LI RJ, Caughey GE, Shakib S
    Appropriateness of inpatient dosing of direct oral anticoagulants for atrial fibrillation.
    J Thromb Thrombolysis. 2021 Jul 24. pii: 10.1007/s11239-021-02528.
    PubMed     Abstract available

  25. KAO CC, Wang T, Parulekar AD
    Need for anticoagulation and use of direct oral anticoagulants in lung transplant recipients.
    J Thromb Thrombolysis. 2021;52:232-238.
    PubMed     Abstract available

  26. ROSSIER C, Spoutz P, Schaefer M, Allen A, et al
    Working smarter, not harder: evaluating a population health approach to anticoagulation therapy management.
    J Thromb Thrombolysis. 2021;52:200-208.
    PubMed     Abstract available

  27. WALLVIK N, Renlund H, Sjalander A
    Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants.
    J Thromb Thrombolysis. 2021;52:315-323.
    PubMed     Abstract available

  28. SYLVESTER KW, Wagner C, Lewin A, Fanikos J, et al
    Reasons for new patient warfarin referrals to an anticoagulant management service in 2019: a single institution experience.
    J Thromb Thrombolysis. 2021;52:158-160.

    June 2021
  29. LU X, Chen T, Liu G, Guo Y, et al
    Relations between left atrial appendage contrast retention and thromboembolic risk in patients with atrial fibrillation.
    J Thromb Thrombolysis. 2021 Jun 15. pii: 10.1007/s11239-021-02490.
    PubMed     Abstract available

    May 2021
  30. PIAZZA G, Hurwitz S, Goldhaber SZ
    Stroke risk factors and outcomes among hospitalized women with atrial fibrillation.
    J Thromb Thrombolysis. 2021 May 26. pii: 10.1007/s11239-021-02482.
    PubMed     Abstract available

  31. BERNAITIS N, Badrick T, Anoopkumar-Dukie S
    Comparison of potential pharmacokinetic drug interactions in patients with atrial fibrillation and changing from warfarin to non-vitamin K oral anticoagulant therapy.
    J Thromb Thrombolysis. 2021 May 7. pii: 10.1007/s11239-021-02466.
    PubMed     Abstract available

  32. GUNER A, Kalcik M, Gunduz S, Gursoy MO, et al
    The relationship between incomplete surgical obliteration of the left atrial appendage and thromboembolic events after mitral valve surgery (from the ISOLATE Registry).
    J Thromb Thrombolysis. 2021;51:1078-1089.
    PubMed     Abstract available

  33. MARCATTO L, Boer B, Sacilotto L, Olivetti N, et al
    Impact of adherence to warfarin therapy during 12 weeks of pharmaceutical care in patients with poor time in the therapeutic range.
    J Thromb Thrombolysis. 2021;51:1043-1049.
    PubMed     Abstract available

    April 2021
  34. VINEREANU D, Napalkov D, Bergler-Klein J, Benczur B, et al
    Patient perceptions of anticoagulant treatment with dabigatran or a vitamin K antagonist for stroke prevention in atrial fibrillation according to region and age: an exploratory analysis from the RE-SONANCE study.
    J Thromb Thrombolysis. 2021 Apr 30. pii: 10.1007/s11239-021-02450.
    PubMed     Abstract available

  35. BARTOLAZZI F, Ribeiro ALP, de Sousa WJFN, Vianna MS, et al
    Relationship of health literacy and adherence to oral anticoagulation therapy in patients with atrial fibrillation: a cross-sectional study.
    J Thromb Thrombolysis. 2021 Apr 15. pii: 10.1007/s11239-021-02432.
    PubMed     Abstract available

    February 2021
  36. LIVNEH N, Braeken D, Drozdinsky G, Gafter-Gvili A, et al
    Anticoagulation in patients with atrial fibrillation, thrombocytopenia and hematological malignancy.
    J Thromb Thrombolysis. 2021 Feb 1. pii: 10.1007/s11239-021-02393.
    PubMed     Abstract available

  37. GAVIN O, Grandes J, Garcia MA, Marzo C, et al
    Treatment preferences as basis for decision making in patients using direct oral anticoagulants in Spain.
    J Thromb Thrombolysis. 2021;51:475-484.
    PubMed     Abstract available

    January 2021
  38. FENG Y, Pai CW, Seiler K, Barnes GD, et al
    Adverse outcomes associated with inappropriate direct oral anticoagulant starter pack prescription among patients with atrial fibrillation: a retrospective claims-based study.
    J Thromb Thrombolysis. 2021 Jan 3. pii: 10.1007/s11239-020-02358.
    PubMed     Abstract available

    Highlights from the European society of cardiology congress 2020.
    J Thromb Thrombolysis. 2021;51:232-236.

    November 2020
  40. DING WY, Lip GYH, Bartoletti S, Morrison L, et al
    Long-term outcomes of left atrial appendage occlusion in high-risk atrial fibrillation patients: 4-year follow up data.
    J Thromb Thrombolysis. 2020 Nov 9. pii: 10.1007/s11239-020-02333.
    PubMed     Abstract available

    October 2020
  41. MARIANI MV, Magnocavallo M, Straito M, Piro A, et al
    Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis.
    J Thromb Thrombolysis. 2020 Oct 12. pii: 10.1007/s11239-020-02304.
    PubMed     Abstract available

    September 2020
  42. PIAZZA G, Hurwitz S, Carroll B, Goldhaber SZ, et al
    Patients with perceived high-bleeding risk and computerized decision support for stroke prevention in atrial fibrillation: an AF-ALERT substudy : Piazza: outcomes of high-bleeding risk AF patients.
    J Thromb Thrombolysis. 2020 Sep 30. pii: 10.1007/s11239-020-02296.
    PubMed     Abstract available

  43. HUANG K, Zha M, Gao J, Du J, et al
    Increased intracranial hemorrhage of mechanical thrombectomy in acute ischemic stroke patients with atrial fibrillation.
    J Thromb Thrombolysis. 2020 Sep 12. pii: 10.1007/s11239-020-02269.
    PubMed     Abstract available

    July 2020
  44. MOHAMED MFH, Elewa H, Mubasher M, Danjuma M, et al
    Direct oral anticoagulants are effective and safe in the treatment of venous thromboembolism and atrial fibrillation in morbidly obese patients.
    J Thromb Thrombolysis. 2020 Jul 31. pii: 10.1007/s11239-020-02238.

  45. CAPPELLARI M, Forlivesi S, Zucchella C, Valbusa V, et al
    Factors influencing cognitive performance after 1-year treatment with direct oral anticoagulant in patients with atrial fibrillation and previous ischemic stroke: a pilot study.
    J Thromb Thrombolysis. 2020 Jul 29. pii: 10.1007/s11239-020-02233.
    PubMed     Abstract available

  46. DIEP R, Garcia D
    Should we monitor the direct oral anticoagulants?
    J Thromb Thrombolysis. 2020;50:30-32.

    June 2020
  47. AMIN A, Keshishian A, Dina O, Dhamane A, et al
    Correction to: Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS Medicare population.
    J Thromb Thrombolysis. 2020 Jun 20. pii: 10.1007/s11239-020-02161.
    PubMed     Abstract available

  48. TZEIS S, Savvari P, Skiadas I, Patsilinakos S, et al
    Right drug, wrong dosage: insights from the PAVE-AF antithrombotic study in older patients with atrial fibrillation.
    J Thromb Thrombolysis. 2020 Jun 9. pii: 10.1007/s11239-020-02167.
    PubMed     Abstract available

    May 2020
  49. LV MN, Zheng XC, Zhang HQ, Xu FD, et al
    Comparison of clinical performance of four gastrointestinal bleeding risk scores in Chinese patients with atrial fibrillation receiving oral anticoagulants.
    J Thromb Thrombolysis. 2020 May 27. pii: 10.1007/s11239-020-02152.
    PubMed     Abstract available

  50. SANTORO F, Brunetti ND, Rillig A, Reissmann B, et al
    Stroke and left atrial thrombi after cryoballoon ablation of atrial fibrillation: incidence and predictors. Results from a long-term follow-up.
    J Thromb Thrombolysis. 2020 May 23. pii: 10.1007/s11239-020-02148.
    PubMed     Abstract available

  51. WANG CL, Wu VC, Huang YT, Chen YL, et al
    Incidence and consequences of resuming oral anticoagulant therapy following hematuria and risks of ischemic stroke and major bleeding in patients with atrial fibrillation.
    J Thromb Thrombolysis. 2020 May 14. pii: 10.1007/s11239-020-02135.
    PubMed     Abstract available

  52. DUARTE RCF, Rios DRA, Figueiredo EL, Caiaffa JRS, et al
    Thrombin Generation and other hemostatic parameters in patients with atrial fibrillation in use of warfarin or rivaroxaban.
    J Thromb Thrombolysis. 2020 May 6. pii: 10.1007/s11239-020-02126.
    PubMed     Abstract available

  53. NEHAJ F, Sokol J, Ivankova J, Mokan M, et al
    Edoxaban affects TRAP-dependent platelet aggregation.
    J Thromb Thrombolysis. 2020;49:578-583.
    PubMed     Abstract available

    April 2020
  54. ZHANG L, Yan X, Fox KAA, Willmann S, et al
    Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in patients with non-valvular atrial fibrillation.
    J Thromb Thrombolysis. 2020 Apr 23. pii: 10.1007/s11239-020-02077.
    PubMed     Abstract available

  55. LIU W, Xiong N, Xie K, Wu B, et al
    A stricter control of low-density lipoprotein is necessary for thrombosis reduction in "lower thrombosis risk" patients with atrial fibrillation: a multicenter retrospective cohort study.
    J Thromb Thrombolysis. 2020 Apr 13. pii: 10.1007/s11239-020-02110.
    PubMed     Abstract available

  56. TOSELLI M, Bosi D, Benatti G, Solinas E, et al
    Left atrial appendage closure: a balanced management of the thromboembolic risk in patients with hemophilia and atrial fibrillation.
    J Thromb Thrombolysis. 2020 Apr 8. pii: 10.1007/s11239-020-02097.
    PubMed     Abstract available

  57. BO M, Brunetti E, Gibello M
    Underuse of anticoagulant therapy in hospitalized older patients: comment on the article of Wojszel et al.
    J Thromb Thrombolysis. 2020;49:499-500.

    February 2020
  58. BERNSTEIN MR, John L, Sciortino S, Arambages E, et al
    Does telehealth improve anticoagulation management in patient service centers (PSC)? A pilot project.
    J Thromb Thrombolysis. 2020;49:316-320.
    PubMed     Abstract available

  59. VEDOVATI MC, Mosconi MG, Isidori F, Agnelli G, et al
    Global thromboelastometry in patients receiving direct oral anticoagulants: the RO-DOA study.
    J Thromb Thrombolysis. 2020;49:251-258.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.